This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A Second Look: Discussing Congenital hyperinsulinism (CHI) and the potential of Rezolute's RZ358

Ticker(s): RZLT

Who's the expert?

Institution: Children's Hospital of Otto von Guericke University

  • Pediatric Endocrinologist and Professor at the Children's Hospital of Otto von Guericke
    University Magdeburg, Germany.
  • Research focuses on bone dysplasia and congenital hyperinsulinism; specializes in metabolic and endocrine diseases and is spokesperson for the Central German Competence Network for Rare Diseases
  • Developed inter-institutional registries for various rare diseases (bone dysplasia, congenital hyperinsulinism, congenital adrenal hyperplasia) to create tools for quality assurance in medicine and has published more than 135 scientific papers in international journals and book chapters

Interview Goal
Discuss clinical data seen so far from RZ358

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.